- Conditions
- Risk of Coronary Obstruction Following Transcatheter Aortic Valve Replacement (TAVR) Procedure
- Interventions
- ShortCut™
- Device
- Lead sponsor
- Pi-cardia
- Industry
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 13
- States / cities
- Tucson, Arizona • Los Angeles, California • San Francisco, California + 10 more
Source: ClinicalTrials.gov public record
Updated Feb 2, 2025 · Synced May 22, 2026, 1:07 AM EDT